AlphaPrime: Using AI to turbocharge clinical trial processes · TechNode
Sharon Chen is the CEO of AlphaPrime, a global health technology company. Prior to founding AlphaPrime, Sharon was the head of Verily China (Alphabet’s
A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE (alpha-emitter) in Subjects With Somatostatin Receptor Positive NETs
FDA accepts first AI algorithm to drug development tool pilot
RuntimeError: Torch is not able to use GPU; add --skip-torch-cuda-test to COMMANDLINE_ARGS variable to disable this check · Issue #349 · Stability-AI/stablediffusion · GitHub
Beyond Discovery: Leveraging AI To Accelerate Clinical Trials
Branded Content Archives · TechNode
D-FW biotech firm completes “first ever” AI clinical trial
Contemporary Competitive Scenario: Analyzing Roche's Emergent Product, Trontinemab
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes
How does Claude, the new LLM from Anthropic compare to ChatGPT? A serious contender, by Cerebrium
Alice Hsu on LinkedIn: AlphaPrime: Using Al to turbocharge clinical trial processes